Matches in SemOpenAlex for { <https://semopenalex.org/work/W4321003841> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W4321003841 endingPage "11" @default.
- W4321003841 startingPage "1" @default.
- W4321003841 abstract "Postoperative nausea and vomiting (PONV) are common unpleasant adverse effects after surgery. The incidence of PONV in pediatric patients is often twice as high as in adults.This study aimed to evaluate the effects of dexmedetomidine, dexamethasone, and ondansetron for preventing PONV in children undergoing dental rehabilitation surgery.A prospective, randomized controlled clinical trial.Sharurah Armed Forces Hospital, Ministry of Defense Medical Services, Saudi Arabia.One hundred patients (6-12 years old) scheduled for dental rehabilitation were included. Patients were randomly allocated into 4 groups (25 each) to receive either 0.15 mg/kg dexamethasone (DEX), 0.05 mg/kg ondansetron (OND), 0.3 microgram/kg dexmedetomidine (DEXMED), or normal saline (control[CONT]) in DEX, OND, DEXMED or CONT groups, respectively, via infusion after induction of anesthesia. The primary outcome was a PONV incident in the first 24 hours. Secondary outcomes were: granisetron doses during 24 hours postoperative, Paediatric Anaesthesia Emergence Delirium (PAED) scale, Pediatric Objective Pain Scale (POPS) for 4 hours postoperatively, and complications in the first 24 hours.The reduction of PONV and the overall number of patients who developed PONV was statistically significant in the DEXMED group compared to the CONT group (P = 0.041). However, the DEXMED group was higher compared to the DEX and OND groups but not statistically significant. Granisetron requirements and doses were statistically significantly lower in the DEXMED group than in the CONT group. PAED and POPS scores were much better in the DEXMED group than in the other groups with a statistically significant difference in most of the time measurements.Optimal dexmedetomidine dose for better effect on PONV without affecting hemodynamic stability requires more studies.Dexmedetomidine is effective in reducing PONV in children undergoing dental rehabilitation with better sedative and analgesic scores as compared to the control group." @default.
- W4321003841 created "2023-02-17" @default.
- W4321003841 creator A5014900932 @default.
- W4321003841 creator A5022807688 @default.
- W4321003841 creator A5026975378 @default.
- W4321003841 creator A5074901404 @default.
- W4321003841 date "2023-01-01" @default.
- W4321003841 modified "2023-09-28" @default.
- W4321003841 title "Effect of Dexmedetomidine, Dexamethasone, and Ondansetron on Postoperative Nausea and Vomiting in Children Undergoing Dental Rehabilitation: A Randomized Controlled Trial." @default.
- W4321003841 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36791288" @default.
- W4321003841 hasPublicationYear "2023" @default.
- W4321003841 type Work @default.
- W4321003841 citedByCount "0" @default.
- W4321003841 crossrefType "journal-article" @default.
- W4321003841 hasAuthorship W4321003841A5014900932 @default.
- W4321003841 hasAuthorship W4321003841A5022807688 @default.
- W4321003841 hasAuthorship W4321003841A5026975378 @default.
- W4321003841 hasAuthorship W4321003841A5074901404 @default.
- W4321003841 hasConcept C126322002 @default.
- W4321003841 hasConcept C141071460 @default.
- W4321003841 hasConcept C168563851 @default.
- W4321003841 hasConcept C197934379 @default.
- W4321003841 hasConcept C2776442465 @default.
- W4321003841 hasConcept C2776814716 @default.
- W4321003841 hasConcept C2777170512 @default.
- W4321003841 hasConcept C2777297131 @default.
- W4321003841 hasConcept C2777452722 @default.
- W4321003841 hasConcept C2780401358 @default.
- W4321003841 hasConcept C2780580376 @default.
- W4321003841 hasConcept C2780651394 @default.
- W4321003841 hasConcept C2780852908 @default.
- W4321003841 hasConcept C2780884295 @default.
- W4321003841 hasConcept C2781302539 @default.
- W4321003841 hasConcept C2781453256 @default.
- W4321003841 hasConcept C42219234 @default.
- W4321003841 hasConcept C71924100 @default.
- W4321003841 hasConceptScore W4321003841C126322002 @default.
- W4321003841 hasConceptScore W4321003841C141071460 @default.
- W4321003841 hasConceptScore W4321003841C168563851 @default.
- W4321003841 hasConceptScore W4321003841C197934379 @default.
- W4321003841 hasConceptScore W4321003841C2776442465 @default.
- W4321003841 hasConceptScore W4321003841C2776814716 @default.
- W4321003841 hasConceptScore W4321003841C2777170512 @default.
- W4321003841 hasConceptScore W4321003841C2777297131 @default.
- W4321003841 hasConceptScore W4321003841C2777452722 @default.
- W4321003841 hasConceptScore W4321003841C2780401358 @default.
- W4321003841 hasConceptScore W4321003841C2780580376 @default.
- W4321003841 hasConceptScore W4321003841C2780651394 @default.
- W4321003841 hasConceptScore W4321003841C2780852908 @default.
- W4321003841 hasConceptScore W4321003841C2780884295 @default.
- W4321003841 hasConceptScore W4321003841C2781302539 @default.
- W4321003841 hasConceptScore W4321003841C2781453256 @default.
- W4321003841 hasConceptScore W4321003841C42219234 @default.
- W4321003841 hasConceptScore W4321003841C71924100 @default.
- W4321003841 hasIssue "1" @default.
- W4321003841 hasLocation W43210038411 @default.
- W4321003841 hasOpenAccess W4321003841 @default.
- W4321003841 hasPrimaryLocation W43210038411 @default.
- W4321003841 hasRelatedWork W1520038824 @default.
- W4321003841 hasRelatedWork W1563063332 @default.
- W4321003841 hasRelatedWork W1824703102 @default.
- W4321003841 hasRelatedWork W2007246622 @default.
- W4321003841 hasRelatedWork W2057593650 @default.
- W4321003841 hasRelatedWork W2563298417 @default.
- W4321003841 hasRelatedWork W3013514534 @default.
- W4321003841 hasRelatedWork W367846217 @default.
- W4321003841 hasRelatedWork W4200452880 @default.
- W4321003841 hasRelatedWork W2338574593 @default.
- W4321003841 hasVolume "26" @default.
- W4321003841 isParatext "false" @default.
- W4321003841 isRetracted "false" @default.
- W4321003841 workType "article" @default.